Study of body fat in people with obstructive sleep apnea
Part of Brain & nervous system, Lungs & breathing clinical trials.
This study looks at how body fat (“adipose tissue”) may differ in people with obstructive sleep apnea. You may be asked for consent and could be asked to stop certain medicines short-term so researchers can take a safe fat sample.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have obstructive sleep apnea
- Your body mass index (BMI) is 40 or less
- You do not currently smoke or use tobacco
- You are not pregnant or breastfeeding, and you do not plan to become pregnant
- You can give written informed consent
- You have certain lab and health exclusions (no active cancer or kidney disease, and no anemia)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a sleep apnea treatment approach and looks at how it may affect your body’s metabolism. You may be eligible if you’re an adult with sleep apnea and meet health and medication rules, and possibly if you already use a PAP machine regularly.
This study is looking at a specific sleep-related condition (obstructive sleep apnea) in adults whose blood pressure is not high, and how their blood pressure rhythm changes over the day. If you have sleep apnea, participating could help researchers understand patterns that may affect long-term health.
This study looks at how bariatric (weight-loss) surgery may change body fat and body shape in people with severe obstructive sleep apnea who use CPAP. It aims to understand what may improve when sleep apnea is better controlled after surgery.
This study looks at people with mild to moderate obstructive sleep apnea (OSA) to understand how inflammation and breathing disruption may affect future heart and metabolism risk. It may help explain why some people develop higher risk even with milder sleep apnea.
This study tests an injected medication to see if it helps reduce the severity of obstructive sleep apnea in people with obesity. The trial will compare the drug to a placebo over several months to check safety and effectiveness.
This study tests whether a new injectable medicine called NNC0487-0111 helps people with excess weight and moderate-to-severe obstructive sleep apnea (a condition where breathing stops repeatedly during sleep) lose weight and improve their sleep apnea—without needing a CPAP machine. The goal is to see if better weight loss can reduce sleep apnea symptoms.
Hear when a new Obstructive Sleep Apnea of Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.